Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells
- PMID: 19887612
- DOI: 10.1158/0008-5472.CAN-09-0550
Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells
Abstract
We have investigated interferon-kappa (IFN-kappa) regulation in the context of human papillomavirus (HPV)-induced carcinogenesis using primary human foreskin keratinocytes (HFK), immortalized HFKs encoding individual oncoproteins of HPV16 (E6, E7, and E6/E7), and cervical carcinoma cells. Here, IFN-kappa was suppressed in the presence of E6, whereas its expression was not affected in HFKs or E7-immortalized HFKs. Transcription could be reactivated after DNA demethylation but was decreased again upon drug removal. Partial reactivation could also be accomplished when E6 was knocked down, suggesting a contribution of E6 in IFN-kappa de novo methylation. We identified a single CpG island near the transcriptional start site as being involved in selective IFN-kappa expression. To prove the functional relevance of IFN-kappa in building up an antiviral response, IFN-kappa was ectopically expressed in cervical carcinoma cells where protection against vesicular stomatitis virus-mediated cytolysis could be achieved. Reconstitution of IFN-kappa was accompanied by an increase of p53, MxA, and IFN-regulatory factors, which was reversed by knocking down either IFN-kappa or p53 by small interfering RNA. This suggests the existence of a positive feedback loop between IFN-kappa, p53, and components of IFN signaling pathway to maintain an antiviral state. Our in vitro findings were further corroborated in biopsy samples of cervical cancer patients, in which IFN-kappa was also downregulated when compared with normal donor tissue. This is the first report showing an epigenetic silencing of type I IFN after HPV16 oncogene expression and revealing a novel strategy on how high-risk HPVs can abolish the innate immune response in their genuine host cells.
Similar articles
-
Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.Oncogene. 2002 Sep 5;21(39):6041-8. doi: 10.1038/sj.onc.1205878. Oncogene. 2002. PMID: 12203116
-
Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.Gynecol Oncol. 2001 Feb;80(2):168-75. doi: 10.1006/gyno.2000.6053. Gynecol Oncol. 2001. PMID: 11161855
-
E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.J Natl Cancer Inst. 2009 Mar 18;101(6):412-23. doi: 10.1093/jnci/djp017. Epub 2009 Mar 10. J Natl Cancer Inst. 2009. PMID: 19276448
-
HPV: from infection to cancer.Biochem Soc Trans. 2007 Dec;35(Pt 6):1456-60. doi: 10.1042/BST0351456. Biochem Soc Trans. 2007. PMID: 18031245 Review.
-
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.Rev Med Virol. 2009 Mar;19(2):97-113. doi: 10.1002/rmv.605. Rev Med Virol. 2009. PMID: 19156753 Review.
Cited by
-
Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.J Virol. 2020 Jan 31;94(4):e01812-19. doi: 10.1128/JVI.01812-19. Print 2020 Jan 31. J Virol. 2020. PMID: 31776268 Free PMC article.
-
Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma.Virol J. 2017 Jan 13;14(1):5. doi: 10.1186/s12985-016-0670-8. Virol J. 2017. PMID: 28086903 Free PMC article.
-
Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.PLoS One. 2012;7(9):e44952. doi: 10.1371/journal.pone.0044952. Epub 2012 Sep 14. PLoS One. 2012. PMID: 23024775 Free PMC article.
-
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.Viruses. 2020 Sep 3;12(9):977. doi: 10.3390/v12090977. Viruses. 2020. PMID: 32899142 Free PMC article. Review.
-
Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin.Oncotarget. 2016 Jul 26;7(30):47777-47793. doi: 10.18632/oncotarget.10013. Oncotarget. 2016. PMID: 27322144 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous